Cellebrite DI Ltd. (CLBT)
CLBT Stock Price Chart
Explore Cellebrite DI Ltd. interactive price chart. Choose custom timeframes to analyze CLBT price movements and trends.
CLBT Company Profile
Discover essential business fundamentals and corporate details for Cellebrite DI Ltd. (CLBT) to support your stock research and investment decisions.
Sector
Technology
Industry
Software - Infrastructure
IPO Date
6 Nov 2020
Employees
1.17K
Website
https://www.cellebrite.comCEO
Thomas E. Hogan
Description
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
CLBT Financial Timeline
Browse a chronological timeline of Cellebrite DI Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is $0.13, while revenue estimate is $122.98M.
Earnings released on 14 Aug 2025
EPS came in at $0.12 surpassing the estimated $0.10 by +20.00%, while revenue for the quarter reached $113.28M , beating expectations by +0.95%.
Earnings released on 14 May 2025
EPS came in at $0.10 surpassing the estimated $0.05 by +90.33%, while revenue for the quarter reached $107.55M , missing expectations by -1.62%.
Earnings released on 13 Feb 2025
EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $109.05M , missing expectations by -0.28%.
Earnings released on 6 Nov 2024
EPS came in at $0.14 surpassing the estimated $0.11 by +27.27%, while revenue for the quarter reached $106.86M , missing expectations by -0.30%.
Earnings released on 15 Aug 2024
EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $95.71M , beating expectations by +4.37%.
Earnings released on 23 May 2024
EPS came in at $0.08 surpassing the estimated $0.06 by +45.45%, while revenue for the quarter reached $89.58M , beating expectations by +4.97%.
Earnings released on 15 Feb 2024
EPS came in at $0.11 surpassing the estimated $0.06 by +83.33%, while revenue for the quarter reached $93.01M , beating expectations by +1.15%.
Earnings released on 14 Nov 2023
EPS came in at $0.09 surpassing the estimated $0.04 by +118.92%, while revenue for the quarter reached $84.18M , missing expectations by -1.59%.
Earnings released on 8 Aug 2023
EPS came in at $0.05 surpassing the estimated $0.02 by +114.32%, while revenue for the quarter reached $76.68M , beating expectations by +5.74%.
Earnings released on 10 May 2023
EPS came in at $0.03 surpassing the estimated $0.02 by +77.83%, while revenue for the quarter reached $71.23M , beating expectations by +2.58%.
Earnings released on 15 Feb 2023
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $74.02M , missing expectations by -0.69%.
Earnings released on 17 Nov 2022
EPS came in at $0.01 falling short of the estimated $0.02 by -55.56%, while revenue for the quarter reached $71.68M , missing expectations by -0.64%.
Earnings released on 11 Aug 2022
EPS came in at $0.17 , while revenue for the quarter reached $62.57M , missing expectations by -9.49%.
Earnings released on 12 May 2022
EPS came in at $0.01 falling short of the estimated $0.02 by -55.56%, while revenue for the quarter reached $62.39M , missing expectations by -0.31%.
Earnings released on 16 Feb 2022
EPS came in at $0.03 surpassing the estimated $0.02 by +33.33%, while revenue for the quarter reached $67.91M , beating expectations by +6.13%.
Earnings released on 10 Nov 2021
EPS came in at $0.08 surpassing the estimated $0.02 by +300.00%, while revenue for the quarter reached $65.89M .
Earnings released on 12 Aug 2021
EPS came in at $0.04 falling short of the estimated $0.05 by -16.70%, while revenue for the quarter reached $59.17M , missing expectations by -27.96%.
Earnings released on 6 Aug 2021
EPS came in at $0.02 , while revenue for the quarter reached $53.28M .
Earnings released on 31 Dec 2020
EPS came in at $0.02 , while revenue for the quarter reached $57.17M .
Earnings released on 30 Sept 2020
EPS came in at $0.04 , while revenue for the quarter reached $53.24M .
CLBT Stock Performance
Access detailed CLBT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.